CDX1 and colorectal carcinoma: Investigations on cancer stem cell subgroups in CRC cell lines revealed a higher portion of cancer stem cells in nondifferentiating cell lines such as HCT116, which is accompanied with loss of CDX1 expression and a more aggressive phenotype (50).